Member Info for JimiHendrix

We know from the New York update and subsequent research that we have some decent HCV sales. I’m confident a placing will now no longer be required during the timeframe we had previously been expecting one. I’m also far more excited about the Covid POC test than the other, we know the test is finished and it’s brilliant… this is a test the FDA will be all over. Autumn is not far away and another global spike will be upon us.

Actually it is true :)

When a person or group acquires interests in shares carrying 30% or more of the voting rights of a company, they must make a cash offer to all other shareholders at the highest price paid in the 12 months before the offer was announced (30% of the voting rights of a company is treated by the Code as the level at which effective control is obtained).

It will be much higher than that imo.

Also I'd expect to hear news about the commercial partners for the POC test soon...

"....Our commercial activities are currently focused on engaging the appropriate commercial partners to be in place in the autumn as the levels of infection undoubtedly rise in many geographies."

They're going to have them in place ready for when the POC gets CE approval. I wondeer if BC will be used for Europe distribution, as it will be launched in Europe first.

Not at all Jaceorge (by the way are you Jason Orange?!)
Actually I use the terms "Should"..."might"..."quite possible that we won't need a fundraise" because we can not know for definite, as with any company if we knew these things were definitely going to happen the shareprice would be many multiples higher than where it is today. The whole concept is about making an educated guess at the likelihood of certain things happening and the effect they will have on the shareprice when the wider market realises.

The problem you're having is clearly with the stock market in general - a savings account is more more suited to some people.

The HCV sales mentioned in the New York article should extend the time Genedrive has before a fundraise would have been neccessary. I'm thinking that might just be enough time for some hearing loss test contracts, POC contracts and EUA... and then it's quite possible we won't need to do a fundraise at all.

I think a fundraise was required by around September if we had no sales. However, we now know they’ve been selling the HCV again. So although there’s probably not been any significant Covid test sales (as he would have mentioned it in the New York article) I’m thinking the HCV sales might keep us going an extra couple months… during which hopefully we see hearing test launch, POC test and maybe maybe EUA at last (though am starting to wonder what the heck is going on with the FDA - nearly end of July now).

Just depends how much they would want to raise and how late they are prepared to leave it.

Interesting that Investec are one of the largest shareholders in Genedrive and currently on the BID looking to buy at this price.

Does anybody (who isn't usually a deramper) think the new market maker could be connected to a potential fundraise?

Budd described the company's HCV test as its business area most impacted by the COVID-19 pandemic.

"HCV is a chronic disease, you can have it for 15 years and not have any symptoms at all," said Budd. "When the world was focusing on COVID, chronic disease was left to the side," he said.

Despite this temporary setback, Budd said sales have resumed in Africa and Asia Pacific, which he described as the primary markets for the test. "We see more activity picking up and I think we can feel positive that it's turned around," he said.

https://www.360dx.com/point-care-testing/genedrive-expects-ce-ivd-mark-poc-sars-cov-2-test-fall-advances-hearing-loss-hcv#.YO2nk5NKgqs

A manuscript is being written at the moment, and Genedrive now plans a commercial launch of the test in the fall. Based on feedback from users, Genedrive is also improving the instrument interface to better address their needs, Budd said.

Hope it goes the same way as ODX and AVCT, their mcaps are 3x and 10x bigger than GDR currently.

Interesting! Are there any more rumours from staff members?

I can't see any sense in a cheap takeover, unless maybe it resulted in a load of shares in BC/D. Genedrive have fully developed products about to be launched, and with plenty of commercial interest. We don't have any problems raising funds if we need to, and we have distribution partners. Seems to me if there is a takeover it would need to be highly rewarding for shareholders.

Apologies, you’re right 2019 it was Tuesday. All other years it’s been Friday. It was even in August one year, though it’s usually around now.

The trading update has always arrived at 7am on a Friday, so I’m expecting it to probably be next Friday now.

They’re probably doing that for search engine visibility and extra traffic, they will have researched popular search phrases and found tons of search volume for the Genedrive kit.

Personally I don't think they're trying to push the shareprice down for a low ball offer at all, that would be an awful thing to do for shareholders plus they have so much money it wouldn't make any difference to them whether they paid 30m or 100m to takeover the company.

The other thing is DB hasn't been that quiet, he has been quiet on the RNS front but every few weeks he's posted something on twitter. I also don't see it would be in DB's best interests to sell the company at the moment, surely with several class leading products about to be launched he will prefer to realise the value himself after all the hard work... rather than give it away for a bargain price. My guess is that Genedrive might be a takeover target in the future or at least part of Genedrive (exclusive rights to certain products perhaps like the PCR test, or an agreement that will allow BC to do FDA submissions directly). However, I believe DB will want as high price as possible and Danaher/BC will be happy to pay it. Also if they wanted to buy the company out cheap they will have already done so, the mcap will be much higher in the next few months... they won't be messing about over a few million here or there... lol they aren't like some of the greedy derampers that try to make holders sell their shares at a loss so that they can buy in 2-5% cheaper. They will calculate likely future returns and offer a fair and attractive price, remember Genedrive isn't falling to pieces needing development help from a big company, the only area we need help with is distribution and we're establishing partnerships for that.

Well for starters I said Genedrive's POC test in particular, as there isn't anything else out there that rivals it. But also there is increasing demand for high quality tests in general, especially now that the cheap Chinese tests have proven to be rubbish. We all know the UK has been committed to buying the cheap rubbish. There will be demand from India too now we have the import license.

PCR testing and in particulat Genedrive's POC test will be in more demand than ever. New cases are now increasing in the United States, France and world wide. Pfizer vacine now shown to be less effective against the Delta variant. The only positive at the moment with Covid is that hospital admissions in well vacinated countries are rising slower than before, but make no mistake about it they are still rising and once restrictions are loosened they will increase substantially and then the autumn will be upon us.

Genedrive is going to do very well.

Covid is on the increase worldwide again now, we are fortunate in the UK to have had such a good vacination system, otherwise we would be in dreadful trouble now. Boris's decision to hopefully take away the restrictions on the 19th is based on that and "if not now then when?" meaning he's fully aware the covid situation is only going to get worse, but as less people are dying than before he's hoping to make the decision (depending on data in the coming week) to open up to help the economy get back on it's feet. It will be at the expense of more deaths and suffering but we can't continue lock downs forever, we have to live with it.

Lol anybody who thinks covid is over has absolutely no idea what is happening! Genedrive will do very well indeed from their next generation tests. New covid cases are going to rocket upwards in the coming weeks and then imagine what will happen when autumn comes. DB knows exactly what he's doing and so does BC and Divoc. Not to mention all the othe brilliant GDR products! :)